Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems


FDA fails to approve cholesterol drug for kidney disease

U.S. health regulators amended the prescribing label for Merck & Co’s cholesterol-lowering drug Vytorin to show it prevents heart problems in patients with chronic kidney disease, but stopped short of approving its use for that purpose.

The decision means Merck cannot market Vytorin as a treatment for reducing the rate of heart problems in… FDA fails to approve cholesterol drug for kidney disease   

kit kat1 - robot-assisted partial nephrectomy1 - early-stage prostate cancer2 - demeclocycline1 - microrna1 - active surveillance1 - absorptive hypercalciurics1 - metastatic prostate cancers1 - ectopic pregnancy2 - thiazide diuretic1 - male potency1 - utero surgery1 - calcifications in the blood vessels1 - plos one1 - citrate4 - syphilis1 - achilles tendon1 - autosomal dominant fsgs1 - x chromosome1 - xenical1 - stis1 - autism1 - kidney damage7 - robotic-surgery1 - urinary tract3 - uterine cancer4 - biopsy outcome1 - vigorous activity1 - renal carcinoma1 - risk of kidney stones1 -